BENICAR HCT 40 MG + 25 MG COM REV CT BL AL/AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1045401730099 -
GGREM
530402009111313 -
Código de barras
7897411610682
O que a fonte publica
- Detentor do registro
- DAIICHI SANKYO BRASIL FARMACÊUTICA LTDA
- Princípios ativos
- HIDROCLOROTIAZIDA;OLMESARTANA MEDOXOMILA
- Embalagem
- 40 MG + 25 MG COM REV CT BL AL/AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- BENICAR HCT 40 MG + 25 MG COM REV CT BL AL/AL X 30
- BENICAR HCT
- HIDROCLOROTIAZIDA
- OLMESARTANA MEDOXOMILA
Dados completos da fonte
{
"name": "BENICAR HCT 40 MG + 25 MG COM REV CT BL AL/AL X 30",
"holder": "DAIICHI SANKYO BRASIL FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7897411610682"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "530402009111313",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.874.187/0001-84",
"priceRegime": "Regulado",
"productName": "BENICAR HCT",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "40 MG + 25 MG COM REV CT BL AL/AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "70.16",
"icms-12": "79.73",
"icms-17": "84.53",
"icms-18": "85.56",
"icms-19": "86.62",
"icms-20": "87.70",
"icms-21": "88.81",
"icms-22": "89.95",
"icms-23": "91.12",
"icms-17.5": "85.04",
"icms-19.5": "87.16",
"icms-20.5": "88.25",
"icms-22.5": "90.53",
"icms-12-alc": "78.77",
"icms-17-alc": "83.52",
"icms-18-alc": "84.53",
"icms-19-alc": "85.58",
"icms-20-alc": "86.65",
"icms-21-alc": "87.74",
"icms-22-alc": "88.87",
"icms-23-alc": "90.02",
"withoutTaxes": "69.32",
"icms-17.5-alc": "84.02",
"icms-19.5-alc": "86.11",
"icms-20.5-alc": "87.19",
"icms-22.5-alc": "89.44"
},
"pisCofinsList": "Positiva",
"substanceText": "HIDROCLOROTIAZIDA;OLMESARTANA MEDOXOMILA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "96.71",
"icms-12": "109.90",
"icms-17": "116.52",
"icms-18": "117.94",
"icms-19": "119.40",
"icms-20": "120.89",
"icms-21": "122.42",
"icms-22": "123.99",
"icms-23": "125.60",
"icms-17.5": "117.22",
"icms-19.5": "120.14",
"icms-20.5": "121.64",
"icms-22.5": "124.79",
"icms-12-alc": "108.89",
"icms-17-alc": "115.46",
"icms-18-alc": "116.86",
"icms-19-alc": "118.31",
"icms-20-alc": "119.79",
"icms-21-alc": "121.30",
"icms-22-alc": "122.86",
"icms-23-alc": "124.45",
"withoutTaxes": "95.83",
"icms-17.5-alc": "116.15",
"icms-19.5-alc": "119.04",
"icms-20.5-alc": "120.54",
"icms-22.5-alc": "123.65"
},
"invalidBarcodes": [],
"activeSubstances": [
"HIDROCLOROTIAZIDA",
"OLMESARTANA MEDOXOMILA"
],
"therapeuticClass": "C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1045401730099",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C9D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:530402009111313"